Display Settings:

Items per page
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 6

1.
Figure 1

Figure 1. From: Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.

Patient disposition. Number of patients lost to follow up (enrolment to baseline+baseline to week 4+week 4 to week 8).

K C H Fearon, et al. Gut. 2003 October;52(10):1479-1486.
2.
Figure 5

Figure 5. From: Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.

Effect of intake of protein and calorie dense oral supplement with n-3 fatty acids on change in weight and lean body mass at eight weeks in patients with pancreatic cancer cachexia.

K C H Fearon, et al. Gut. 2003 October;52(10):1479-1486.
3.
Figure 4

Figure 4. From: Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.

Relationship between oral supplement intake, with or without n-3 fatty acids, and weight (A, B) or lean body mass (C, D) of patients with pancreatic cancer cachexia after eight weeks of supplementation.

K C H Fearon, et al. Gut. 2003 October;52(10):1479-1486.
4.
Figure 6

Figure 6. From: Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.

Relationship between plasma phospholipid eicosapentaenoic acid (EPA) levels and change in lean body mass at eight weeks in patients consuming the protein and calorie dense oral supplement with n-3 fatty acids.

K C H Fearon, et al. Gut. 2003 October;52(10):1479-1486.
5.
Figure 2

Figure 2. From: Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.

Effect of protein and calorie dense oral supplements, with or without n-3 fatty acids, on weight change in patients with pancreatic cancer cachexia. *NS (p = 0.49) at baseline, 0.95 at four weeks, and 0.74 at eight weeks between groups; **p<0.001 within group comparisons to baseline.

K C H Fearon, et al. Gut. 2003 October;52(10):1479-1486.
6.
Figure 3

Figure 3. From: Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.

Effect of protein and calorie dense oral supplements, with or without n-3 fatty acids, on change in lean body mass in patients with pancreatic cancer cachexia. *NS (p = 0.85) at baseline, 0.95 at four weeks, and 0.88 at eight weeks between groups; **p<0.001 within group comparisons to baseline.

K C H Fearon, et al. Gut. 2003 October;52(10):1479-1486.

Display Settings:

Items per page

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk